It was the first time to determine the role of circSLC7A6 in WT, and we discovered that circSLC7A6 promoted WT progression via the miR-107/ABL2 axis, implying a novel and possible tactic for WT treatment.
CircSLC7A6 promotes the progression of Wilm tumor via microRNA-107/ ABL proto-oncogene 2 axis.